申请人:Sankyo Company, Limited
公开号:EP1695962A1
公开(公告)日:2006-08-30
A compound having the general formula (I) (wherein R1 represents C1-C6 alkyl, etc., R2 represents hydrogen, C2-C7 alkanoyl, C7-C11 arylcarbonyl, the formula R4-(CH2)1-, etc., R3 represents C6-C10 aryl, etc., X1, X2, X3, X4 and X5 each independently represents hydrogen, halogen, etc., and n represents an integer of 0 to 2), pharmacologically acceptable salts thereof or prodrugs thereof. They have excellent inhibition of platelet activation, etc. and are useful as a prophylactic or therapeutic agents for diseases related to thrombus or embolus formation.
具有通式(I)的化合物(其中R1代表C1-C6烷基等,R2代表氢、C2-C7烷酰基、C7-C11芳羰基、式R4-(CH2)1-等,R3代表C6-C10芳基等,X1、X2、X3、X4和X5各自独立地代表氢、卤素等,n代表0至2的整数)、其药理学上可接受的盐或其原药。它们对血小板活化等有很好的抑制作用,可作为血栓或栓子形成相关疾病的预防或治疗药物。